PPARγ as a potential target to treat airway mucus hypersecretion in chronic airway inflammatory diseases

PPAR Research

Volumn , Issue , 2012, Pages

  Shen, Yongchun ^a   Chen, Lei ^a   Wang, Tao ^a   Wen, Fuqiang ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACROLEIN; CIGARETTE SMOKE; CIGLITAZONE; COMPLEMENTARY DNA; CYTOKINE; DNA; INTERLEUKIN 1BETA; INTERLEUKIN 8; MESSENGER RNA; MUCIN; OVALBUMIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PIOGLITAZONE; ROSIGLITAZONE; TOLUENE DIISOCYANATE; TRANSCRIPTION FACTOR; TROGLITAZONE; TUMOR NECROSIS FACTOR ALPHA;

AIRWAY; AIRWAY MUCUS HYPERSECRETION; AIRWAY OBSTRUCTION; ANTIINFLAMMATORY ACTIVITY; ASTHMA; CHRONIC LUNG DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYSTIC FIBROSIS; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG TARGETING; EMPHYSEMA; HUMAN; IMMUNE SYSTEM; INFLAMMATION; INFLAMMATORY DISEASE; LUNG ALVEOLUS MACROPHAGE; MUCUS SECRETION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; REVIEW;

EID: 84863643545     PISSN: 16874757     EISSN: 16874765     Source Type: Journal    
DOI: 10.1155/2012/256874     Document Type: Review

References (64)

1. Fahy J. V., Dickey B. F., Medical progress: airway mucus function and dysfunction New England Journal of Medicine 2010 363 23 2233 2247
2. Wen F. Q., Shen Y. C., Expectorant therapy revisited in chronic obstructive pulmonary disease Chinese Journal of Tuberculosis and Respiratory Diseases 2011 34 4 243 245
3. Berger J., Moller D. E., The mechanisms of action of PPARs Annual Review of Medicine 2002 53 409 435 (Pubitemid 34177889)
4. Belvisi M. G., Mitchell J. A., Targeting PPAR receptors in the airway for the treatment of inflammatory lung disease British Journal of Pharmacology 2009 158 4 994 1003
5. Ward J. E., Tan X., Peroxisome proliferator activated receptor ligands as regulators of airway inflammation and remodelling in chronic lung disease PPAR Research 2007 2007 12
6. Remels A. H., Gosker H. R., Schrauwen P., Langen R. C., Schols A. M., Peroxisome proliferator-activated receptors: a therapeutic target in COPD? European Respiratory Journal 2008 31 3 502 508
7. Lakatos H. F., Thatcher T. H., Kottmann R. M., Garcia T. M., Phipps R. P., Sime P. J., The role of PPARs in lung fibrosis PPAR Research 2007 2007 10
8. Nisbet R. E., Sutliff R. L., Hart C. M., The role of peroxisome proliferator-activated receptors in pulmonary vascular disease PPAR Research 2007 2007 10
9. Di Paola R., Cuzzocrea S., Peroxisome proliferator-activated receptors and acute lung injury PPAR Research 2007 2007 8
10. Keshamouni V. G., Han S., Roman J., Peroxisome proliferator-activated receptors in lung cancer PPAR Research 2007 2007 10
11. Belvisi M. G., Hele D. J., Birrell M. A., Peroxisome proliferator- activated receptor gamma agonists as therapy for chronic airway inflammation European Journal of Pharmacology 2006 533 13 101 109 (Pubitemid 43340008)
12. Rogers D. F., Airway goblet cells: responsive and adaptable frontline defenders European Respiratory Journal 1994 7 9 1690 1706 (Pubitemid 24294257)
13. Sethi S., Murphy T. F., Infection in the pathogenesis and course of chronic obstructive pulmonary disease New England Journal of Medicine 2008 359 22 2355 2365
14. Speizer F. E., Fay M. E., Dockery D. W., Ferris B. G., Chronic obstructive pulmonary disease mortality in six U.S. cities American Review of Respiratory Disease 1989 140 3 S49 S55
15. Vestbo J., Prescott E., Lange P., Jensen G., Schnohr P., Appleyard M., Nyboe J., Grnbk M., Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity American Journal of Respiratory and Critical Care Medicine 1996 153 5 1530 1535 (Pubitemid 26141336)
16. Burgel P. R., Nesme-Meyer P., Chanez P., Caillaud D., Carré P., Perez T., Roche N., Cough and sputum production are associated with frequent exacerbations and hospitalizations in COPD subjects Chest 2009 135 4 975 982
17. De Marco R., Accordini S., Cerveri I., Corsico A., Ant J. M., Knzli N., Janson C., Sunyer J., Jarvis D., Chinn S., Vermeire P., Svanes C., Ackermann-Liebrich U., Gislason T., Heinrich J., Leynaert B., Neukirch F., Schouten J. P., Wjst M., Burney P., Incidence of chronic obstructive pulmonary disease in a cohort of young adults according to the presence of chronic cough and phlegm American Journal of Respiratory and Critical Care Medicine 2007 175 1 32 39 (Pubitemid 46105306)
18. Kohansal R., Martinez-Camblor P., Agust A., Sonia Buist A., Mannino D. M., Soriano J. B., The natural history of chronic airflow obstruction revisited: an analysis of the Framingham Offspring Cohort American Journal of Respiratory and Critical Care Medicine 2009 180 1 3 10
19. Kuyper L. M., Paré P. D., Hogg J. C., Lambert R. K., Ionescu D., Woods R., Bai T. R., Characterization of airway plugging in fatal asthma American Journal of Medicine 2003 115 1 6 11 (Pubitemid 36831115)
20. Siroux V., Boudier A., Bousquet J., Bresson J. L., Cracowski J. L., Ferran J., Gormand F., Just J., Le Moual N., Morange S., Nadif R., Oryszczyn M. P., Pison C., Scheinmann P., Varraso R., Vervloet D., Pin I., Kauffmann F., Phenotypic determinants of uncontrolled asthma Journal of Allergy and Clinical Immunology 2009 124 4 681.e3 687.e3
21. Henke M. O., Ratjen F., Mucolytics in cystic fibrosis Paediatric Respiratory Reviews 2007 8 1 24 29 (Pubitemid 46523789)
22. Baginski T. K., Dabbagh K., Satjawatcharaphong C., Swinney D. C., Cigarette smoke synergistically enhances respiratory mucin induction by proinflammatory stimuli American Journal of Respiratory Cell and Molecular Biology 2006 35 2 165 174 (Pubitemid 44175315)
23. Arai N., Kondo M., Izumo T., Tamaoki J., Nagai A., Inhibition of neutrophil elastase-induced goblet cell metaplasia by tiotropium in mice European Respiratory Journal 2010 35 5 1164 1171
24. Klinger J. D., Tandler B., Liedtke C. M., Boat T. F., Proteinases of Pseudomonas aeruginosa evoke mucin release by tracheal epithelium Journal of Clinical Investigation 1984 74 5 1669 1678 (Pubitemid 15214078)
25. Lora J. M., Zhang D. M., Liao S. M., Burwell T., King A. M., Barker P. A., Singh L., Keaveney M., Morgenstern J., Gutiérrez-Ramos J. C., Coyle A. J., Fraser C. C., Tumor necrosis factor- triggers mucus production in airway epithelium through an I B kinase -dependent mechanism Journal of Biological Chemistry 2005 280 43 36510 36517 (Pubitemid 41633925)
26. Fujisawa T., Velichko S., Thai P., Hung L. Y., Huang F., Wu R., Regulation of airway MUC5AC expression by IL-1 and IL-17A; the NF- B paradigm Journal of Immunology 2009 183 10 6236 6243
27. Chen Y., Thai P., Zhao Y. H., Ho Y. S., DeSouza M. M., Wu R., Stimulation of airway mucin gene expression by interleukin (IL)-17 through IL-6 paracrine/autocrine loop Journal of Biological Chemistry 2003 278 19 17036 17043 (Pubitemid 36799579)
28. Bautista M. V., Chen Y., Ivanova V. S., Rahimi M. K., Watson A. M., Rose M. C., IL-8 regulates mucin gene expression at the posttranscriptional level in lung epithelial cells Journal of Immunology 2009 183 3 2159 2166
29. Zhert G., Sung W. P., Nguyenvu L. T., Rodriguez M. W., Barbeau R., Paquet A. C., Erie D. J., IL-13 and epidermal growth factor receptor have critical but distinct roles in epithelial cell mucin production American Journal of Respiratory Cell and Molecular Biology 2007 36 2 244 253 (Pubitemid 46233478)
30. Evans C. M., Koo J. S., Airway mucus: the good, the bad, the sticky Pharmacology and Therapeutics 2009 121 3 332 348
31. Decramer M., Janssens W., Mucoactive therapy in copd European Respiratory Review 2010 19 116 134 140
32. Belvisi M. G., Hele D. J., Peroxisome proliferator-activated receptors as novel targets in lung disease Chest 2008 134 1 152 157 (Pubitemid 352008777)
33. Simon D. M., Arikan M. C., Srisuma S., Bhattacharya S., Andalcio T., Shapiro S. D., Mariani T. J., Epithelial cell PPAR is an endogenous regulator of normal lung maturation and maintenance Proceedings of the American Thoracic Society 2006 3 6 510 511 (Pubitemid 44285538)
34. Asada K., Sasaki S., Suda T., Chida K., Nakamura H., Antiinflammatory roles of peroxisome proliferator-activated receptor in human alveolar macrophages American Journal of Respiratory and Critical Care Medicine 2004 169 2 195 200
35. Woerly G., Honda K., Loyens M., Papin J. P., Auwerx J., Staels B., Capron M., Dombrowicz D., Peroxisome proliferator-activated receptors and down-regulate allergic inflammation and eosinophil activation Journal of Experimental Medicine 2003 198 3 411 421 (Pubitemid 36976052)
36. Yang X. Y., Wang L. H., Chen T., Hodge D. R., Resau J. H., DaSilva L., Farrar W. L., Activation of human T lymphocytes is inhibited by peroxisome proliferator-activated receptor (PPAR ) agonists. PPAR co-association with transcription factor NFAT Journal of Biological Chemistry 2000 275 7 4541 4544 (Pubitemid 30108833)
37. Chinetti G., Griglio S., Antonucci M., Torra I. P., Delerive P., Majd Z., Fruchart J. C., Chapman J., Najib J., Staels B., Activation of proliferator-activated receptors and induces apoptosis of human monocyte-derived macrophages Journal of Biological Chemistry 1998 273 40 25573 25580 (Pubitemid 28475776)
38. Faveeuw C., Fougeray S., Angeli V., Fontaine J., Chinetti G., Gosset P., Delerive P., Maliszewski C., Capron M., Staels B., Moser M., Trottein F., Peroxisome proliferator-activated receptor activators inhibit interleukin-12 production in murine dendritic cells FEBS Letters 2000 486 3 261 266
39. Li J., Dai A., Hu R., Zhu L., Tan S., Positive correlation between PPAR /PGC-1 and -GCS in lungs of rats and patients with chronic obstructive pulmonary disease Acta Biochimica et Biophysica Sinica 2010 42 9 603 614
40. Perez A., Van Heeckeren A. M., Nichols D., Gupta S., Eastman J. F., Davis P. B., Peroxisome proliferator-activated receptor- in cystic fibrosis lung epithelium American Journal of Physiology 2008 295 2 L303 L313
41. Kobayashi M., Thomassen M. J., Rambasek T., Bonfield T. L., Raychaudhuri B., Malur A., Winkler A. R., Barna B. P., Goldman S. J., Kavuru M. S., An inverse relationship between peroxisome proliferator-activated receptor and allergic airway inflammation in an allergen challenge model Annals of Allergy, Asthma and Immunology 2005 95 5 468 473 (Pubitemid 41688509)
42. Trifilieff A., Bench A., Hanley M., Bayley D., Campbell E., Whittaker P., PPAR- and- but not- agonists inhibit airway inflammation in a murine model of asthma: in vitro evidence for an NF- B-independent effect British Journal of Pharmacology 2003 139 1 163 171 (Pubitemid 36645320)
43. Lee K. S., Park S. J., Hwang P. H., Yi H. K., Song C. H., Chai O. H., Kim J. S., Lee M. K., Lee Y. C., PPAR-gamma modulates allergic inflammation through up-regulation of PTEN FASEB Journal 2005 19 8 1033 1035 (Pubitemid 40827742)
44. Park Y. S., Lillehoj E. P., Kato K., Park C. S., Kim K. C., PPAR inhibits airway epithelial cell inflammatory response through a MUC1-dependent mechanism American Journal of Physiology 2012 302 7 L679 L687
45. Neri T., Armani C., Pegoli A., Cordazzo C., Carmazzi Y., Brunelleschi S., Bardelli C., Breschi M. C., Paggiaro P., Celi A., Role of NF- B and PPAR- in lung inflammation induced by monocyte-derived microparticles European Respiratory Journal 2011 37 6 1494 1502
46. Straus D. S., Glass C. K., Anti-inflammatory actions of PPAR ligands: new insights on cellular and molecular mechanisms Trends in Immunology 2007 28 12 551 558 (Pubitemid 350101420)
47. Lee S. Y., Kang E. J., Hur G. Y., Ki H. J., Hye C. J., Sang Y. L., Je H. K., Shin C., Kwang H. I., Kyung H. K., Se H. Y., Shim J. J., Peroxisome proliferator-activated receptor- inhibits cigarette smoke solution-induced mucin production in human airway epithelial (NCI-H292) cells American Journal of Physiology 2006 291 1 L84 L90
48. Wu Q., Jiang D., Chu H. W., Cigarette smoke induces growth differentiation factor 15 production in human lung epithelial cells: implication in mucin over-expression. Innate Immunity. In press
49. Liu D. S., Liu W. J., Chen L., Ou X. M., Wang T., Feng Y. L., Zhang S. F., Xu D., Chen Y. J., Wen F. Q., Rosiglitazone, a peroxisome proliferator-activated receptor- agonist, attenuates acrolein-induced airway mucus hypersecretion in rats Toxicology 2009 260 13 112 119
50. Imanifooladi A. A., Yazdani S., Nourani M. R., The role of nuclear factor- B in inflammatory lung disease Inflammation and Allergy 2010 9 3 197 205
51. Ou X. M., Feng Y. L., Wen F. Q., Wang K., Yang J., Deng Z. P., Liu D. S., Li Y. P., Macrolides attenuate mucus hypersecretion in rat airways through inactivation of NF- B Respirology 2008 13 1 63 72
52. Honda K., Marquillies P., Capron M., Dombrowicz D., Peroxisome proliferator-activated receptor is expressed in airways and inhibits features of airway remodeling in a mouse asthma model Journal of Allergy and Clinical Immunology 2004 113 5 882 888 (Pubitemid 38608597)
53. Lee K. S., Park S. J., Kim S. R., Min K. H., Jin S. M. I., Lee H. K., Lee Y. C., Modulation of airway remodeling and airway inflammation by peroxisome proliferator-activated receptor in a murine model of toluene diisocyanate-induced asthma Journal of Immunology 2006 177 8 5248 5257 (Pubitemid 44527597)
54. Hetzel M., Walcher D., Grb M., Bach H., Hombach V., Marx N., Inhibition of MMP-9 expression by PPAR activators in human bronchial epithelial cells Thorax 2003 58 9 778 783 (Pubitemid 37094054)
55. Ren S., Guo L. L., Yang J., Liu D. S., Wang T., Chen L., Chen Y. J., Xu D., Feng Y. L., Wen F. Q., Doxycycline attenuates acrolein-induced mucin production, in part by inhibiting MMP-9 European Journal of Pharmacology 2011 650 1 418 423
56. Chen Y. J., Chen P., Wang H. X., Wang T., Chen L., Wang X., Sun B. B., Liu D. S., Xu D., An J., Wen F. Q., Simvastatin attenuates acrolein-induced mucin production in rats: involvement of the Ras/extracellular signal-regulated kinase pathway International Immunopharmacology 2010 10 6 685 693
57. Shen Y., Wu H., Wang C., Shao H., Huang H., Jing H., Li D., Simvastatin attenuates cardiopulmonary bypass-induced myocardial inflammatory injury in rats by activating peroxisome proliferator-activated receptor European Journal of Pharmacology 2010 649 13 255 262
58. Mueller C., Weaver V., Vanden Heuvel J. P., August A., Cantorna M. T., Peroxisome proliferator-activated receptor ligands attenuate immunological symptoms of experimental allergic asthma Archives of Biochemistry and Biophysics 2003 418 2 186 196 (Pubitemid 37159385)
59. Ward J. E., Fernandes D. J., Taylor C. C., Bonacci J. V., Quan L., Stewart A. G., The PPAR ligand, rosiglitazone, reduces airways hyperresponsiveness in a murine model of allergen-induced inflammation Pulmonary Pharmacology and Therapeutics 2006 19 1 39 46 (Pubitemid 41606851)
60. Nissen S. E., Wolski K., Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes New England Journal of Medicine 2007 356 24 2457 2471 (Pubitemid 46919772)
61. Dahabreh I. J., Meta-analysis of rare events: an update and sensitivity analysis of cardiovascular events in randomized trials of rosiglitazone Clinical Trials 2008 5 2 116 120 (Pubitemid 351682521)
62. Drummond M. B., Dasenbrook E. C., Pitz M. W., Murphy D. J., Fan E., Inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis Journal of the American Medical Association 2008 300 20 2407 2416
63. Balsamo R., Lanata L., Egan C. G., Mucoactive drugs European Respiratory Review 2010 19 116 127 133
64. Spears M., Donnelly I., Jolly L., Brannigan M., Ito K., McSharry C., Lafferty J., Chaudhuri R., Braganza G., Bareille P., Sweeney L., Adcock I. M., Barnes P. J., Wood S., Thomson N. C., Bronchodilatory effect of the PPAR- agonist rosiglitazone in smokers with asthma Clinical Pharmacology and Therapeutics 2009 86 1 49 53